PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cochrane Review of dihydroartemisinin-piperaquine

Cochrane review of dihydroartemisinin-piperaquine for treating uncomplicated malaria

2014-01-22
(Press-News.org) Contact information: Clare Bebb
c.bebb@liv.ac.uk
44-015-170-53135
Liverpool School of Tropical Medicine
Cochrane Review of dihydroartemisinin-piperaquine Cochrane review of dihydroartemisinin-piperaquine for treating uncomplicated malaria 'Dihydroartemisinin-piperaquine is more effective than artemether-lumefantrine, and has fewer side effects than artesunate-mefloquine' concludes a systematic review published by the Cochrane Infectious Disease Group, hosted by LSTM.

Dihydroartemisinin-piperaquine is one of five artemisinin-based combination therapies currently recommended by the World Health Organization (WHO), and this review finds that it is also one of the most studied. The team of authors from South Africa, Kenya, Geneva and Liverpool included 27 randomized studies, enrolling 16,382 adults and children, which directly compared the relative efficacy and safety of dihydroartemisinin-piperaquine and the widely used alternatives; artemether-lumefantrine, artesunate plus mefloquine, and artesunate plus amodiaquine.

"The very long duration of action of piperaquine in this combination, means that DHA-P reduces the risk of the person suffering another bout of malaria for up to nine weeks after treatment", explained David Sinclair from LSTM. "This gives it an advantage over most of the other combinations. Mefloquine has a similarly long duration of action but commonly causes side-effects such as nausea, vomiting and dizziness."

Dihydroartemisinin-piperaquine also became one of the few antimalarials to be formally registered by a stringent regulatory authority when the European Medicines Agency approved it for use in 2013. The registration process highlighted concerns that dihydroartemisinin-piperaquine caused some short term changes in electrocardiographs tracing the conduction of the heart rhythm. The review also examined this effect, and the authors report that the number of people affected by these changes is small and all resolved spontaneously without serious consequences.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Researchers identify innate channel that protects against pain

2014-01-22
Researchers identify innate channel that protects against pain Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today ...

Study: Electric drive vehicles have little impact on US pollutant emissions

2014-01-22
Study: Electric drive vehicles have little impact on US pollutant emissions A new study from North Carolina State University indicates that even a sharp increase in the use of electric drive passenger vehicles (EDVs) by 2050 would not significantly reduce ...

Study: 'Icy' technique improves robotic kidney transplants

2014-01-22
Study: 'Icy' technique improves robotic kidney transplants DETROIT – A collaboration of surgeons at Henry Ford Hospital and Medanta Hospital in India successfully transplanted kidneys into 50 recipients using an innovative robot-assisted procedure in which ...

More diseases from air pollution uncovered by improved data material

2014-01-22
More diseases from air pollution uncovered by improved data material At rest, we breathe approx. 12-15 times per minute, and for each inhalation we change approx. one litre of air. Depending on the activity level, this makes up a daily quantity in the order of twenty cubic metres ...

Understanding the functioning of a new type of solar cell

2014-01-21
Understanding the functioning of a new type of solar cell Photovoltaic energy conversion offers one of the best means for the future of renewable energy in the world. The efficiency of solar cells depends heavily upon the light-absorbing materials ...

DNA barcodes change our view on how nature is structured

2014-01-21
DNA barcodes change our view on how nature is structured How you seek is what you find To understand how feeding interactions are structured, researchers from Finland and Canada chose to focus on one of the simplest food webs on Earth: the moths and butterflies ...

Quality control of mitochondria as a defense against disease

2014-01-21
Quality control of mitochondria as a defense against disease HEIDELBERG, 20 January 2014 – Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson's disease are ...

Ultra-thin tool heating for injection molding

2014-01-21
Ultra-thin tool heating for injection molding If you have ever tried to make waffles then you are bound to be familiar with the following problem: You only get good waffles if the iron is heated to the correct temperature. The same principle ...

Hydrocephalus: Sensors monitor cerebral pressure

2014-01-21
Hydrocephalus: Sensors monitor cerebral pressure Urinary incontinence, a shuffling gait, and deteriorating reasoning skills are all indicators pointing to a Parkinsonian or Alzheimer type disease. An equally plausible explanation is hydrocephalus, ...

Micropredators dictate occurrence of deadly amphibian disease

2014-01-21
Micropredators dictate occurrence of deadly amphibian disease A new study raises hope to successfully fight the chytrid amphibian pathogen This news release is available in German. Leipzig: An international team of researchers has made ...

LAST 30 PRESS RELEASES:

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

More scrutiny of domestic fishing fleets at ports could help deter illegal fishing

Scientists transform plastic waste into efficient CO2 capture materials

Discovery of North America’s role in Asia’s monsoons offers new insights into climate change

MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies

Researchers discover massive geo-hydrogen source to the west of the Mussau Trench

Even untouched ecosystems are losing insects at alarming rates, new study finds

Adaptive visible-infrared camouflage with wide-range radiation control for extreme ambient temperatures

MD Anderson research highlights for September 5, 2025

Physicists create a new kind of time crystal that humans can actually see

Reminder: Final media invitation for EPSC-DPS2025 and details of media briefings on RAMSES and Juno missions

Understanding orderly and disorderly behavior in 2D nanomaterials could enable bespoke design, tailored by AI

JAMA Network launches JAMA+ Women's Health

Surface plasmon driven atomic migration mediated by molecular monolayer

ERC Starting Grant for five University of Groningen scientists

AI turns printer into a partner in tissue engineering

[Press-News.org] Cochrane Review of dihydroartemisinin-piperaquine
Cochrane review of dihydroartemisinin-piperaquine for treating uncomplicated malaria